These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 16956430)
1. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis. Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P Clin Exp Rheumatol; 2006; 24(4):400-6. PubMed ID: 16956430 [TBL] [Abstract][Full Text] [Related]
2. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Fishman P; Bar-Yehuda S; Madi L; Rath-Wolfson L; Ochaion A; Cohen S; Baharav E Arthritis Res Ther; 2006; 8(1):R33. PubMed ID: 16507132 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression. Ochaion A; Bar-Yehuda S; Cohn S; Del Valle L; Perez-Liz G; Madi L; Barer F; Farbstein M; Fishman-Furman S; Reitblat T; Reitblat A; Amital H; Levi Y; Molad Y; Mader R; Tishler M; Langevitz P; Zabutti A; Fishman P Arthritis Res Ther; 2006; 8(6):R169. PubMed ID: 17101059 [TBL] [Abstract][Full Text] [Related]
5. The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats. Ochaion A; Bar-Yehuda S; Cohen S; Amital H; Jacobson KA; Joshi BV; Gao ZG; Barer F; Patoka R; Del Valle L; Perez-Liz G; Fishman P Biochem Pharmacol; 2008 Aug; 76(4):482-94. PubMed ID: 18602896 [TBL] [Abstract][Full Text] [Related]
6. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling. Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967 [TBL] [Abstract][Full Text] [Related]
7. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors. Tian Y; Marshall M; French BA; Linden J; Yang Z Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314 [TBL] [Abstract][Full Text] [Related]
8. Caspase inhibition via A3 adenosine receptors: a new cardioprotective mechanism against myocardial infarction. Hussain A; Gharanei AM; Nagra AS; Maddock HL Cardiovasc Drugs Ther; 2014 Feb; 28(1):19-32. PubMed ID: 24220799 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331 [TBL] [Abstract][Full Text] [Related]
10. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists. Szabó C; Scott GS; Virág L; Egnaczyk G; Salzman AL; Shanley TP; Haskó G Br J Pharmacol; 1998 Sep; 125(2):379-87. PubMed ID: 9786512 [TBL] [Abstract][Full Text] [Related]
11. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations. Mlejnek P; Dolezel P; Frydrych I J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730 [TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism. Mlejnek P; Dolezel P Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715 [TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein mediates resistance to A3 adenosine receptor agonist 2-chloro-N6-(3-iodobenzyl)-adenosine-5'-n-methyluronamide in human leukemia cells. Mlejnek P; Dolezel P; Kosztyu P J Cell Physiol; 2012 Feb; 227(2):676-85. PubMed ID: 21520073 [TBL] [Abstract][Full Text] [Related]
14. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling. Ren TH; Lv MM; An XM; Leung WK; Seto WK J Dig Dis; 2020 Jan; 21(1):38-45. PubMed ID: 31714673 [TBL] [Abstract][Full Text] [Related]
15. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway. Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375 [TBL] [Abstract][Full Text] [Related]
16. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells. Kim TH; Kim YK; Woo JS Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643 [TBL] [Abstract][Full Text] [Related]
17. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells. Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194 [TBL] [Abstract][Full Text] [Related]
18. Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration. Galvao J; Elvas F; Martins T; Cordeiro MF; Ambrósio AF; Santiago AR Exp Eye Res; 2015 Nov; 140():65-74. PubMed ID: 26297614 [TBL] [Abstract][Full Text] [Related]
19. Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation. Sandhu H; Cooper S; Hussain A; Mee C; Maddock H Eur J Pharmacol; 2017 Nov; 814():95-105. PubMed ID: 28811127 [TBL] [Abstract][Full Text] [Related]
20. Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells. Morello S; Sorrentino R; Porta A; Forte G; Popolo A; Petrella A; Pinto A J Cell Physiol; 2009 Nov; 221(2):378-86. PubMed ID: 19562684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]